Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares stock (CUPR) is currently trading at $0.33. Cuprina Holdings (Cayman) Limited Class A Ordinary Shares PS ratio (Price-to-Sales) is 232.67. WallStSmart rates CUPR as Sell.
- CUPR PE ratio analysis and historical PE chart
- CUPR PS ratio (Price-to-Sales) history and trend
- CUPR intrinsic value — DCF, Graham Number, EPV models
- CUPR stock price prediction 2025 2026 2027 2028 2029 2030
- CUPR fair value vs current price
- CUPR insider transactions and insider buying
- Is CUPR undervalued or overvalued?
- Cuprina Holdings (Cayman) Limited Class A Ordinary Shares financial analysis — revenue, earnings, cash flow
- CUPR Piotroski F-Score and Altman Z-Score
- CUPR analyst price target and Smart Rating
Cuprina Holdings (Cayman) Limited Class A
📊 No data available
Try selecting a different time range
Smart Analysis
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Key Strengths (1)
Trading at 1.15x book value, attractively priced
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -43.90%, a shrinking business
Very expensive at 232.7x annual revenue
Very low institutional interest at 0.66%
Micro-cap company with very limited liquidity and high volatility
Supporting Valuation Data
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) Detailed Analysis Report
Overall Assessment
This company scores 16/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 1 register as strengths (avg 8.0/10) while 6 fall into concern territory (avg 1.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book. Valuation metrics including Price/Book (1.15) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (232.67) suggest expensive pricing. Growth concerns include Revenue Growth at -43.90%, which may limit upside. Profitability pressure is visible in Return on Equity at -139.10%, Operating Margin at -8643.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -139.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -43.90% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CUPR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CUPR's Price-to-Sales ratio of 232.67x trades 31% below its historical average of 337.64x (39th percentile). The current valuation is 80% below its historical high of 1187.34x set in Jul 2025, and 297% above its historical low of 58.68x in Feb 2026. Over the past 12 months, the PS ratio has compressed from ~722.5x as trailing revenue scaled faster than the stock price.
Compare CUPR with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares operates as a stable business with moderate growth and solid fundamentals. Revenue reached 30,330 with 44% decline year-over-year.
Key Findings
Spending 796% of revenue (241,362) on R&D, reinforcing its commitment to innovation and future growth.
Revenue contracted 44% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -1M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Cuprina Holdings (Cayman) Limited Class A Ordinary Shares.
Bottom Line
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares(CUPR)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds.